Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Hepatol Res. 2007 Sep;37 Suppl 2:S135-8. doi: 10.1111/j.1872-034X.2007.00176.x.
As is observed in many types of human cancers, hepatocellular carcinoma (HCC) is characterized by an obvious multistage process of tumor progression. Histopathological and molecular biological studies have revealed that HCC associated with chronic liver disease evolves from precancerous lesions called adenomatous hyperplasia (also called dysplastic nodules) and early HCC to a progressed form. Early HCC corresponds to in situ or microinvasive carcinoma, and develops to progressed HCC through the stage of "nodule-in-nodule" type HCC (progressed HCC within early HCC), which indicates a transition from early to progressed HCC. It is consideredthat early HCC is a key step in the process of HCC development and progression. However, the molecular mechanisms of early hepatocarcinogenesis are far from clear. Specific mutations of classical oncogenes or tumor suppressor genes have not been identified in early HCC so far. Recent progress in comprehensive analysis of gene expression is shedding some light on this issue.
在许多类型的人类癌症中都可以观察到,肝细胞癌(HCC)的特征是肿瘤进展的明显多阶段过程。组织病理学和分子生物学研究表明,与慢性肝病相关的 HCC 是从称为腺瘤性增生(也称为异型增生结节)和早期 HCC 的癌前病变发展而来的。早期 HCC 对应于原位或微侵袭性癌,并通过“结节内结节”型 HCC(早期 HCC 内的进展性 HCC)的阶段发展为进展性 HCC,这表明从早期到进展性 HCC 的转变。人们认为早期 HCC 是 HCC 发展和进展过程中的关键步骤。然而,早期肝癌发生的分子机制尚不清楚。迄今为止,尚未在早期 HCC 中发现经典癌基因或肿瘤抑制基因的特定突变。基因表达综合分析的最新进展为此问题提供了一些线索。